Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients

Appendectomy correlates with increased risk of pyogenic liver abscess

(2016) Kuan-Fu Liao et al.   MEDICINE

Feasibility of Outpatient 24-Hour Closed-Loop Insulin Delivery: Table 1

(2015) Martin I. de Bock et al.   DIABETES CARE

Impact of Asthma on the Development of Coronary Vasospastic Angina

(2015) Ming-Jui Hung et al.   MEDICINE

Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies

(2014) Shang-Hung Chang et al.   Cardiovascular Diabetology

Rosiglitazone Attenuates Atrial Structural Remodeling and Atrial Fibrillation Promotion in Alloxan-Induced Diabetic Rabbits

(2014) Tong Liu et al.   Cardiovascular Therapeutics

The combined effect of metformin and l-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats

(2013) Zenat K. Salman et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Metformin Attenuates the Exacerbation of the Allergic Eosinophilic Inflammation in High Fat-Diet-Induced Obesity in Mice

(2013) Marina Ciarallo Calixto et al.   PLoS One

Incidence and Prevalence of Atrial Fibrillation and Associated Mortality Among Medicare Beneficiaries: 1993–2007

(2012) Jonathan P. Piccini et al.  

Type 2 Diabetes Mellitus and Risk of Incident Atrial Fibrillation in Women

(2012) Tobias Schoen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus

(2011) Evren Fidan et al.   ACTA DIABETOLOGICA

Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation

(2011) Rachel R. Huxley et al.   AMERICAN JOURNAL OF CARDIOLOGY

Insulin Resistance and Atrial Fibrillation (from the Framingham Heart Study)

(2011) João D. Fontes et al.   AMERICAN JOURNAL OF CARDIOLOGY

Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes

(2011) Yung-Hsin Yeh et al.   CARDIOVASCULAR RESEARCH

Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus

(2011) J. Gu et al.   EUROPACE

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study

(2011) Rachel R Huxley et al.   HEART

Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes

(2011) Tze-Fan Chao et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation

(2011) David Conen   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Recent advances in the molecular pathophysiology of atrial fibrillation

(2011) Reza Wakili et al.   JOURNAL OF CLINICAL INVESTIGATION

Pathophysiological Mechanisms of Atrial Fibrillation: A Translational Appraisal

(2011) Ulrich Schotten et al.   PHYSIOLOGICAL REVIEWS

Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats

(2010) Osamu Kume et al.   HEART RHYTHM

Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation

(2010) Sascha Dublin et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation

(2010) Usha B. Tedrow et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women

(2009) David Conen et al.   CIRCULATION

Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation

(2009) G. A. Nichols et al.   DIABETES CARE

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy

(2007) Panagiotis Korantzopoulos et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The potential role of thiazolidinediones in atrial fibrillation

(2007) Tong Liu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY